Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trial.

ElSherif MS, Brown C, MacKinnon-Cameron D, Li L, Racine T, Alimonti J, Rudge TL, Sabourin C, Silvera P, Hooper JW, Kwilas SA, Kilgore N, Badorrek C, Ramsey WJ, Heppner DG, Kemp T, Monath TP, Nowak T, McNeil SA, Langley JM, Halperin SA; Canadian Immunization Research Network.

CMAJ. 2017 Jun 19;189(24):E819-E827. doi: 10.1503/cmaj.170074.

2.

Challenges, progress, and opportunities: proceedings of the filovirus medical countermeasures workshop.

Hirschberg R, Ward LA, Kilgore N, Kurnat R, Schiltz H, Albrecht MT, Christopher GW, Nuzum E.

Viruses. 2014 Jul 9;6(7):2673-97. doi: 10.3390/v6072673.

3.

An interagency collaboration to facilitate development of filovirus medical countermeasures.

Kilgore N, Nuzum EO.

Viruses. 2012 Oct 19;4(10):2312-6. doi: 10.3390/v4102312.

4.

Elevated temperature triggers human respiratory syncytial virus F protein six-helix bundle formation.

Yunus AS, Jackson TP, Crisafi K, Burimski I, Kilgore NR, Zoumplis D, Allaway GP, Wild CT, Salzwedel K.

Virology. 2010 Jan 20;396(2):226-37. doi: 10.1016/j.virol.2009.10.040. Epub 2009 Nov 18.

5.

Anti-AIDS agents 73: structure-activity relationship study and asymmetric synthesis of 3-O-monomethylsuccinyl-betulinic acid derivatives.

Qian K, Nakagawa-Goto K, Yu D, Morris-Natschke SL, Nitz TJ, Kilgore N, Allaway GP, Lee KH.

Bioorg Med Chem Lett. 2007 Dec 1;17(23):6553-7.

6.

Anti-AIDS agents 72. Bioisosteres (7-carbon-DCKs) of the potent anti-HIV lead DCK.

Wang Y, Huang SX, Xia P, Xia Y, Yang ZY, Kilgore N, Morris-Natschke SL, Lee KH.

Bioorg Med Chem Lett. 2007 Aug 1;17(15):4316-9. Epub 2007 May 16.

7.

Rubrisandrins A and B, lignans and related anti-HIV compounds from Schisandra rubriflora.

Chen M, Kilgore N, Lee KH, Chen DF.

J Nat Prod. 2006 Dec;69(12):1697-701.

PMID:
17190445
8.

Determinants of activity of the HIV-1 maturation inhibitor PA-457.

Li F, Zoumplis D, Matallana C, Kilgore NR, Reddick M, Yunus AS, Adamson CS, Salzwedel K, Martin DE, Allaway GP, Freed EO, Wild CT.

Virology. 2006 Dec 5-20;356(1-2):217-24. Epub 2006 Aug 22.

9.

Anti-AIDS agents. Part 56: Synthesis and anti-HIV activity of 7-thia-di-O-(-)-camphanoyl-(+)-cis-khellactone (7-thia-DCK) analogs.

Chen Y, Zhang Q, Zhang B, Xia P, Xia Y, Yang ZY, Kilgore N, Wild C, Morris-Natschke SL, Lee KH.

Bioorg Med Chem. 2004 Dec 15;12(24):6383-7.

PMID:
15556756
10.

3-O-Glutaryl-dihydrobetulin and related monoacyl derivatives as potent anti-HIV agents.

Kashiwada Y, Sekiya M, Ikeshiro Y, Fujioka T, Kilgore NR, Wild CT, Allaway GP, Lee KH.

Bioorg Med Chem Lett. 2004 Dec 6;14(23):5851-3.

PMID:
15501054
11.

Defining the parameters necessary for T-cell recognition of ligands that vary in potency.

Kilgore NE, Ford ML, Margot CD, Jones DS, Reichardt P, Evavold BD.

Immunol Res. 2004;29(1-3):29-40. Review.

PMID:
15181268
12.

Anti-AIDS agents. Part 58: synthesis and anti-HIV activity of 1-thia-di-O-(-)-camphanoyl-(+)-cis-khellactone (1-thia-DCK) analogues.

Xia P, Yin ZJ, Chen Y, Zhang Q, Zhang B, Xia Y, Yang ZY, Kilgore N, Wild C, Morris-Natschke SL, Lee KH.

Bioorg Med Chem Lett. 2004 Jun 21;14(12):3341-3.

PMID:
15149703
13.

PA-457: a potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing.

Li F, Goila-Gaur R, Salzwedel K, Kilgore NR, Reddick M, Matallana C, Castillo A, Zoumplis D, Martin DE, Orenstein JM, Allaway GP, Freed EO, Wild CT.

Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13555-60. Epub 2003 Oct 22.

14.
15.

Cutting edge: dependence of TCR antagonism on Src homology 2 domain-containing protein tyrosine phosphatase activity.

Kilgore NE, Carter JD, Lorenz U, Evavold BD.

J Immunol. 2003 May 15;170(10):4891-5.

16.

Anti-HIV agents. Part 55: 3'R,4'R-Di-(O)-(-)-camphanoyl-2',2'-dimethyldihydropyrano[2,3-f]chromone (DCP), a novel anti-HIV agent.

Yu D, Brossi A, Kilgore N, Wild C, Allaway G, Lee KH.

Bioorg Med Chem Lett. 2003 May 5;13(9):1575-6.

PMID:
12699758
17.

Anti-HIV agents derived from the ent-kaurane diterpenoid linearol.

Bruno M, Rosselli S, Pibiri I, Kilgore N, Lee KH.

J Nat Prod. 2002 Nov;65(11):1594-7.

PMID:
12444682
18.

Anti-AIDS agents. 48.(1) Anti-HIV activity of moronic acid derivatives and the new melliferone-related triterpenoid isolated from Brazilian propolis.

Ito J, Chang FR, Wang HK, Park YK, Ikegaki M, Kilgore N, Lee KH.

J Nat Prod. 2001 Oct;64(10):1278-81.

PMID:
11678650
19.

Anti-AIDS agents. Part 47: Synthesis and anti-HIV activity of 3-substituted 3',4'-Di-O-(S)-camphanoyl-(3'R,4'R)-(+)-cis-khellactone derivatives.

Xie L, Allaway G, Wild C, Kilgore N, Lee KH.

Bioorg Med Chem Lett. 2001 Sep 3;11(17):2291-3.

PMID:
11527717
20.

Anti-HIV and cytotoxic activities of Ru(II)/Ru(III) polypyridyl complexes containing 2,6-(2'-benzimidazolyl)-pyridine/chalcone as co-ligand.

Mishra L, Sinha R, Itokawa H, Bastow KF, Tachibana Y, Nakanishi Y, Kilgore N, Lee KH.

Bioorg Med Chem. 2001 Jul;9(7):1667-71.

PMID:
11425566
21.

Pleuropulmonary amebiasis.

KILGORE NA Jr.

South Med J. 1951 Dec;44(12):1093-6. No abstract available.

PMID:
14884012

Supplemental Content

Loading ...
Support Center